Benzinga | Feb 24, 2021 04:26PM EST

Amedisys Q4 EPS $1.49 Beats $1.47 Estimate, Sales $550.70M Miss $553.37M Estimate

Amedisys (NASDAQ:AMED) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.47 by 1.36 percent. This is a 58.51 percent increase over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $550.70 million which missed the analyst consensus estimate of $553.37 million by 0.48 percent. This is a 9.99 percent increase over sales of $500.68 million the same period last year.